Article ID Journal Published Year Pages File Type
3293551 Gastroenterology 2012 13 Pages PDF
Abstract
We designed an orally administered RNPO that accumulates specifically in the colons of mice with colitis and is more effective in reducing inflammation than low-molecular-weight TEMPOL or mesalamine. RNPO might be developed for treatment of patients with ulcerative colitis.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Gastroenterology
Preview
An Orally Administered Redox Nanoparticle That Accumulates in the Colonic Mucosa and Reduces Colitis in Mice
Authors
, , , , ,